Patents by Inventor Alexander Cobb

Alexander Cobb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof
    Patent number: 12403136
    Abstract: The present invention relates to a group of cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof. The cannabinoid derivatives of the invention are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: September 2, 2025
    Assignee: JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
    Inventors: Alan Silcock, Benjamin Whalley, Royston Gray, Hannah Straker, Karen Tse, Alexander Cobb, Laura Bryant
  • CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF PREPARATION THEREOF
    Publication number: 20220288055
    Abstract: The present invention relates to a group of cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof. The cannabinoid derivatives of the invention are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders.
    Type: Application
    Filed: July 17, 2020
    Publication date: September 15, 2022
    Inventors: Alan SILCOCK, Benjamin WHALLEY, Royston GRAY, Hannah STRAKER, Karen TSE, Alexander COBB, Laura BRYANT
  • Treatment and prevention of tissue damage
    Publication number: 20060019930
    Abstract: An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of being bound by ligand binding sites present on the CRP molecules; or (ii) at least one of the ligands is capable of being bound by a ligand binding site present on a CRP molecule, and at least one other of the ligands is capable of being bound by a ligand binding site present on a serum amyloid P component (SAP) molecule.
    Type: Application
    Filed: May 14, 2003
    Publication date: January 26, 2006
    Inventors: Mark Pepys, Steven Ley, Alexander Cobb